CD38 and epilepsy: Notably, CD38, a transmembrane glycoprotein, emerged as a key player in epilepsy pathogenesis due to its involvement in NAD+ degradation and intracellular calcium ion balance (Guerreiro et al., 2020; Khodaverdian et al., 2021).